Abiopharma

🔍 REINER GARY M (Director)

Company: Hewlett Packard Enterprise Co (HPE)

Report Date: 2026-05-01

Detailed Transactions and Holdings:

• Holds 0 shares of Common Stock (Direct)
  Date: 2026-05-01 | Code: H | Footnotes: F1
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-05-01 | Code: H | nature_of_ownership: By JPM Chase | shares_owned_after: 102,941.00 | Footnotes: F2
• Acquired 8,750 shares of Restricted Stock Units (Derivative)
  Date: 2026-05-01 | Code: A | equity_swap_involved: 0 | shares_owned_after: 8,750.00 | transaction_form_type: 4 | Footnotes: F3, F4, F4, F4, F4

Footnotes:

• F1: The total direct beneficial ownership reflects a decrease of 16,295 shares due to transfer of the shares into the reporting person's JP Morgan Chase account on 04/08/26.
• F2: The total indirect beneficial ownership reflects an increase of 16,295 shares due to transfer of the shares previously reported as being held directly by the reporting person into his JPMorgan Chase account on 04/08/26.
• F3: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.
• F4: On 05/01/26, the reporting person was granted 8,750 restricted stock units ("RSUs"), all of which will cliff vest on the earlier of 05/01/27 or the date of Issuer's 2027 Annual Stockholders Meeting. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on Issuer's common stock.